Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosa

Xin Fang, Jonathan M. Monk, Nathan Mih, Bin Du, Anand Sastry, Erol S. Kavvas, Yara Seif, Larry Smarr, Bernhard O. Palsson. Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosa. BMC Systems Biology, 12(1), 2018. [doi]

@article{FangMMDSKSSP18,
  title = {Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosa},
  author = {Xin Fang and Jonathan M. Monk and Nathan Mih and Bin Du and Anand Sastry and Erol S. Kavvas and Yara Seif and Larry Smarr and Bernhard O. Palsson},
  year = {2018},
  doi = {10.1186/s12918-018-0587-5},
  url = {https://doi.org/10.1186/s12918-018-0587-5},
  researchr = {https://researchr.org/publication/FangMMDSKSSP18},
  cites = {0},
  citedby = {0},
  journal = {BMC Systems Biology},
  volume = {12},
  number = {1},
}